SCHEMBL5867261

SCHEMBL5867261

CS(=O)(=O)c1cccc(CC(=O)NC[C@H]2CN(Cc3ccc(Cl)c(Cl)c3)CCO2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR3 P51677 2/20 0.54
DRD4 P21917 4/20 0.46
SIGMAR1 Q99720 3/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HTT P42858 2/20 0.44
MAPT P10636 1/20 0.44
KCNH2 Q12809 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
HTR1A P08908 1/20 0.43
ADRA2A P08913 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CYP2C9 P11712 1/20 0.43
ADRA2B P18089 1/20 0.43
HTR2C P28335 1/20 0.43
SLC6A4 P31645 1/20 0.43
CYP2C19 P33261 1/20 0.43
DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5867264 1.00 CCR3 (0.54) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL5832890 1.00 CCR3 (0.54) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL5832699 0.92 DRD4 (0.48) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL5832651 0.92 CCR3 (0.53) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL4027406 0.91 CCR3 (0.56) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL5832596 0.91 CCR3 (0.56) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL4026470 0.91 CCR3 (0.57) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL4022549 0.91 CCR3 (0.57) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL4027488 0.91 CCR3 (0.57) CCR3DRD4SIGMAR1MEN1KMT2A
SCHEMBL5832019 0.91 CCR3 (0.52) CCR3DRD4SIGMAR1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2006504625-A 2006-02-09 JP claimed
EP-1492537-A1 MORPHOLINE DERIVATIVES WITH A SUBSTITUTED ACETAMIDE GROUP IN THE 2-POSITION FOR USE AS CCR-3 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2005-01-05 EP claimed
WO-2003082294-A1 MORPHOLINE DERIVATIVES WITH A SUBSTITUTED ACETAMIDE GROUP IN THE 2-POSITION FOR USE AS CCR-3 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2003-10-09 WO claimed